본문 바로가기

5-Fluorouracil crystal-incorporated, pH-responsive, and release-modulating PLGA/Eudragit FS hybrid microparticles for local colorectal cancer-targeted chemotherapy

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
INTERNATIONAL JOURNAL OF PHARMACEUTICS630 · #122443 · 2023
피인용
Web of Science 21Scopus 21
FWCI (Scopus)
1.55
JCR IF
JCR 2022 5.8
ISSN
0378-5173

저자

  1. 이주호제1저자Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  2. 배준환Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  3. 곽동민Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  4. 김현우Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  5. 김지현Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  6. 쉐이 퓨 랑이Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  7. 사파르바예바 아루잔Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  8. Lee, Eun HeeKorea Univ, Coll Pharm, Sejong 30019, South Korea
  9. 윤인수Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  10. 김민수Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  11. 문형룡Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
  12. 유진욱교신저자Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea

초록

5-Fluorouracil (5-FU) is a widely used chemotherapeutic agent for colorectal cancer (CRC) owing to its potent anticancer effects. However, severe systemic side effects and poor drug accumulation in the CRC tissues limit its efficacy. This study aimed to develop 5-FU crystal-incorporated, pH-responsive, and release-modulating poly(D,L- lactide-co-glycolide)/Eudragit FS hybrid microparticles (5FU-EPMPs) for the local CRC-targeted chemotherapy. Approximately 150 mu m 5FU-EPMPs were fabricated via the S/O/W emulsion solvent evaporation method, with 7.93 +/- 0.24% and 87.23 +/- 2.64% 5-FU loading and encapsulation efficiencies, respectively. Drug release profiles in a simulated pH environment of the gastrointestinal tract revealed that premature 5-FU release in the stomach and small intestine was prevented, thereby minimizing systemic 5-FU absorption. After reaching the colon, 5-FU was continuously released for >15 h, allowing long-term exposure of CRC tissues to sufficient 5-FU concentra-tions. Furthermore, in a CRC mouse model, the 5FU-EPMPs showed potent inhibition of tumor growth without signs of systemic toxicity. Thus, the 5FU-EPMPs represent a promising drug delivery system for local CRC -targeted chemotherapy.

키워드

5-fluorouracilpH-responsiveRelease modulationColorectal cancerColon-targeted deliveryLocal chemotherapyMESOPOROUS SILICA NANOPARTICLESCOLON-CANCERDRUG-DELIVERYMURINE COLITISDESIGNMICROSPHERES

식별자

Scopus EID
2-s2.0-85143511611
WoS UID
000897037200003